| Name | Title | Contact Details |
|---|
Tasty Restaurant Group LLC (TRG) is based in Dallas, Texas, and focuses on operating and expanding a portfolio of popular restaurant brands. As an affiliate of Triton Pacific Capital Partners, TRG emphasizes the importance of strong teams in delivering exceptional service and quality to guests, which is vital for the success of its brands. The company provides operational and managerial support to its restaurants, concentrating on talent development, guest experiences, and community engagement. TRG operates a diverse range of franchised restaurants, including well-known names like Pizza Hut, Burger King, Dunkin, Baskin-Robbins, Kentucky Fried Chicken (KFC), and Taco Bell. With a presence in at least 21 states, TRG aims to improve existing locations and expand through strategic acquisitions, supported by a leadership team with extensive experience in the restaurant industry.
Accounting 501 (formerly Pery Consulting Group, founded by Rafe Pery) includes a team of 25 consultants with a broad range of experience in the non-profit sector from the day-to-day transactional accounting level up to the CFO level. Accounting 501 works exclusively in the non-profit sector and assists organizations that are experiencing rapid growth or operational challenges such as…a financial crisis, staffing transitions, accounting system clean-up, merger/reorganization, the need to establish and/or fine tune systems, policies, and procedures. At Accounting 501, we specialize in assisting organizations with complex private and public funding sources to maximize grants and contracts and to ensure compliance with grant requirements. We understand the importance of cost allocation as well as cost center reporting as key to meeting the goals of the organization.
Based in Austin, Texas, TimberTown Specialty Building Products supplies high quality lumber and building materials for a wide variety of residential and commercial projects. Our products range from high-end exotic hardwoods, softwoods and composites; often specially milled for different applications. The types of projects we supply can be as simple as a small residential outdoor cedar deck, to the very complex hardwood siding for a multi-million dollar custom home or a rooftop patio on a downtown high-rise. With such a large and diverse client base, we excel in providing exceptional service for contractors and commercial builders, architects, designers and their clients.
AMB Sports and Entertainment, based in Atlanta, Georgia, is a dynamic organization under the Blank Family of Businesses, led by entrepreneur Arthur Blank. The company manages a diverse portfolio that includes professional sports teams, venues, and retail operations. Key components of AMB Sports and Entertainment include the NFLs Atlanta Falcons, the MLSs Atlanta United FC, and the Atlanta Drive GC, which is set to debut in the Tomorrow Golf League in 2025. The company operates the Mercedes-Benz Stadium, a versatile venue for sports and major events, and The Home Depot Backyard, an outdoor space for community activities. Additionally, it runs the PGA TOUR Superstore, a nationwide golf retail chain. AMBSE Ventures focuses on strategic investments in sports technology and entertainment. The organization is committed to community engagement through various initiatives, including diversity programs and large-scale events. With a dedicated leadership team and a growing workforce, AMB Sports and Entertainment continues to enhance its impact in the sports and entertainment landscape.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.